Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 272,860 | 85,662 | 104,645 | 59,758 | 62,379 |
| Marketable Securities | 63,056 | 76,861 | 77,293 | 118,707 | 133,418 |
| Receivables | 185 | 213 | 2,313 | 240 | 285 |
| Other current assets | 0 | 55 | 0 | 207 | 113 |
| TOTAL | $340,680 | $166,909 | $188,147 | $183,313 | $199,606 |
| Non-Current Assets | |||||
| PPE Net | 4,319 | 4,604 | 4,392 | 3,701 | 3,370 |
| Investments And Advances | 0 | 0 | 0 | 2,025 | 0 |
| Intangibles | 2,699 | 2,699 | 2,699 | 2,699 | 2,699 |
| Other Non-Current Assets | 4,157 | 3,670 | 3,890 | 1,143 | 1,185 |
| TOTAL | $11,175 | $10,973 | $10,981 | $9,568 | $7,254 |
| Total Assets | $351,855 | $177,882 | $199,128 | $192,881 | $206,860 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,364 | 3,700 | 6,596 | 517 | 1,426 |
| Accrued Expenses | 7,499 | 6,336 | 8,824 | 9,041 | 7,313 |
| TOTAL | $60,635 | $37,126 | $35,767 | $23,682 | $22,224 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 46,772 | 27,090 | 20,347 | 14,124 | 13,485 |
| Other Non-Current Liabilities | 1,391 | 978 | 566 | 154 | 153 |
| TOTAL | $238,983 | $66,969 | $84,882 | $79,777 | $83,449 |
| Total Liabilities | $299,618 | $104,095 | $120,649 | $103,459 | $105,673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,867 | 36,750 | 36,518 | 36,402 | 36,288 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -209,839 | -184,623 | -176,366 | -162,333 | -147,671 |
| Other shareholders' equity | -110 | -100 | -27 | 6 | 80 |
| TOTAL | $52,237 | $73,787 | $78,479 | $89,422 | $101,187 |
| Total Liabilities And Equity | $351,855 | $177,882 | $199,128 | $192,881 | $206,860 |